serotype-specific whole-cell pneumococcal vaccines
Vaccinemarketed
Approved
Jul 1, 1918
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1910s
- Jul 1, 1918
Evidence of US Marketing
Indications
Approved for
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Approval history
- approvedJul 1, 1918
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- serotype-specific whole-cell pneumococcal vaccine
- serotype-specific whole-cell pneumococcal vaccines